Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2010-01-31
2018-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. To determine whether a higher amount of fat calories per day within a normal range in a Nutritional Insufficiency patient's diet will lead to a shorter inpatient hospital stay duration.
2. To determine whether a higher amount of fat calories per day within a normal range in a Nutritional Insufficiency patient's diet will lead to less gastrointestinal re-feeding syndrome symptoms.
3. To determine whether a higher amount of fat calories per day within a normal range in a Nutritional Insufficiency patient's diet will effect their body image and/or alter their mood.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Re-nutrition in Severe Anorexia Nervosa
NCT02502617
A fMRI Pilot Study of the Effects of Meal-support in Eating Disorders.
NCT02551445
Reward Systems and Food Avoidance in Eating Disorders
NCT02795455
The Effects of Nutritional Intervention in Participants With Eating Disorders.
NCT06230107
Testing an Internet-Based Intervention for Preventing Eating Disorders
NCT00934583
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Research Procedures
Patients will be placed into one of two groups:
1. Control: Intake 35-50 grams of fat per day between meals and snacks - this is the typical amount used within our current inpatient re-feeding meal plan, still within a healthy range as it is at the lower end of normal, which given that these patients typically consume a "low fat" diet prior to admission that this amount has been the standard of care for treatment thus far, if they require any supplemental feedings for incomplete meals it will be with the standard lower fat content supplements
2. Treatment: Intake \> 50 grams of fat per day between meals and snacks - still within a healthy range as it is at the higher end of normal, if they require any supplemental feedings for incomplete meals it will be with a higher fat content supplement as dictated by the nutrition therapists
Study instruments - questionnaires distributed and collected on the initial day of admission, on every third day of inpatient stay and on the day of discharge by the nutrition therapists. Due to the lack of research on this method of treatment, there are no questionnaires which have been tested for validity and reliability; therefore we have created our own, which we plan to assess during this pilot study. We also plan to follow-up with the patient and parent(s) at 1 month post-discharge (+/- 1 day) to assess how their re-feeding treatment has been going, along with to assess how they feel and ask about any symptoms they are experiencing.
Tests and procedures - all patients with Nutritional Insufficiency/Eating Disorders admitted to the Cleveland Clinic Children's Hospital follow the Nutritional Insufficiency Protocol, with all screening tests and inpatient evaluation and follow-up occurring regardless of whether they are involved in the current pilot study. As per protocol, these patients will be on strict bed rest with a 24 hour companion supervising the patient at all times, especially monitoring intake and timing of completion of all meals, snacks and/or supplements. It is also standard per protocol that they receive Neutra-phos which is a potassium phosphate and sodium phosphate supplement, twice daily for the initial 5 days of treatment. The screening, daily inpatient evaluation, and study questionnaire distribution will be completed on admission, every 3 days, and at discharge
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Arm = Decreased Energy Density
Decreased energy density = 35-50 grams of fat per day between meals and snacks
Low fat intake
low fat intake : Intake 35-50 grams of fat per day between meals and snacks
Treatment Arm = Increased Energy Density
increased increased energy density : Intake \> 50 grams of fat per day between meals and snacks
Increased fat intake
increased fat intake : Intake \> 50 grams of fat per day between meals and snacks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Low fat intake
low fat intake : Intake 35-50 grams of fat per day between meals and snacks
Increased fat intake
increased fat intake : Intake \> 50 grams of fat per day between meals and snacks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Elevated pancreatic enzymes,
* Expected admission \< 24 hours duration,
* Admission on weekends.
9 Years
24 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Cleveland Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ellen Rome
Staff, General Pediatrics
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ellen Rome, MD
Role: PRINCIPAL_INVESTIGATOR
The Cleveland Clinic
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CCCH-KW
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.